Cited by 626Alzheimer's disease research and treatmentsSphingolipid Metabolism and SignalingDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

Han, Xianlin, M. Holtzman, David, W. McKeel, Daniel, Kelley, John, Morris, John C.·2002·Journal of Neurochemistry

DOI 10.1046/j.1471-4159.2002.00997.x

Open this paper in CoChat — free account

Abstract

In addition to pathology in the gray matter, there are also abnormalities in the white matter in Alzheimer's disease (AD). Sulfatide species are a class of myelin‐specific sphingolipids and are involved in certain diseases of the central nervous system. To assess whether sulfatide content in gray and white matter in human subjects is associated with both the presence of Alzheimer's disease (AD) pathology as well as the stage of dementia, we analyzed the sulfatide content of brain tissue lipid extracts by electrospray ionization mass spectrometry from 22 subjects whose cognitive status at time of death varied from no dementia to very severe dementia. All subjects with dementia had AD pathology. The results demonstrate that: (i) sulfatides were depleted up to 93% in gray matter and up to 58% in white matter from all examined brain regions from AD subjects with very mild dementia, whereas all other major classes of lipid (except plasmalogen) in these subjects were not altered in comparison to those from age‐matched subjects with no dementia; (ii) there was no apparent deficiency in the biosynthesis of sulfatides in very mild AD subjects as characterized by the examination of galactocerebroside sulfotransferase activities in post‐mortem brain tissues; (iii) the content of ceramides (a class of potential degradation products of sulfatides) was elevated more than three‐fold in white matter and peaked at the stage of very mild dementia. The findings demonstrate that a marked decrease in sulfatides is associated with AD pathology even in subjects with very mild dementia and that these changes may be linked with early events in the pathological process of AD.

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2002.00997.x

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citation
Functions of Ceramide in Coordinating Cellular Responses to Stress
Hannun, Y. A. (1996) · Science · doi:10.1126/science.274.5294.1855 · Cited by 1,612
A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
Brun, A., & Englund, E. (1986) · Annals of Neurology · doi:10.1002/ana.410190306 · Cited by 1,014
Alzheimer's Disease--Genotypes, Phenotype, and Treatments
Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 879
REGULATION OF CERAMIDE PRODUCTION AND APOPTOSIS
Kolesnick, R., & Krönke, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.643 · Cited by 803
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype
Berg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657
Self-citation
Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and Pathophysiology
Merrill, A. H., Schmelz, E.-M., Dillehay, D. L., Spiegel, S., Shayman, J. A., Schroeder, J. J., Riley, R. T., Voss, K. A., & Wang, E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8029 · Cited by 643
Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability
Coetzee, T., Fujita, N., Dupree, J. L., Shi, R., Blight, A. R., Suzuki, K., Suzuki, K., & Popko, B. (1996) · Cell · doi:10.1016/s0092-8674(00)80093-8 · Cited by 624

Show all 56 references

Research works printed but not linked: 5

10.1139/y59-099 · DOI · Paper page
10.1042/bj3520079 · DOI
Kolodny E. H., 1995, The Metabolic and Molecular Bases of Inherited Diseases, 2693
Mattson M. P., 1997, Mother's legacy: mitochondrial DNA mutations and Alzheimer's disease, Trends Neurosci., 20, 373
Suzuki K., 1995, The Metabolic and Molecular Bases of Inherited Diseases, 2671

Sorted by citations

Items 201–300 of 625

Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?
Chiurchiù, V., Tiberi, M., Matteocci, A., Fazio, F., Siffeti, H., Saracini, S., Mercuri, N. B., & Sancesario, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116235 · Cited by 73
Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia
Ohtani, R., Tomimoto, H., Kondo, T., Wakita, H., Akiguchi, I., Shibasaki, H., & Okazaki, T. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.024 · Cited by 65
The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives
Lucaciu, A., Brunkhorst, R., Pfeilschifter, J. M., Pfeilschifter, W., & Subburayalu, J. (2020) · Cells · doi:10.3390/cells9061515 · Cited by 67
The Involvement of Lipids in Alzheimer's Disease
Lim, W. L. F., Martins, I. J., & Martins, R. N. (2014) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2014.04.003 · Cited by 67
Activation of large-conductance Ca2+-activated K+ channels depresses basal synaptic transmission in the hippocampal CA1 area in APP (swe/ind) TgCRND8 mice
Ye, H., Jalini, S., Mylvaganam, S., & Carlen, P. L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.012 · Cited by 63
Accelerated decline in white matter integrity in clinically normal individuals at risk for Alzheimer's disease
Rieckmann, A., Dijk, K. R. A. V., Sperling, R. A., Johnson, K. A., Buckner, R. L., & Hedden, T. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.016 · Cited by 67
Nano-HPLC–MS analysis of phospholipids in cerebrospinal fluid of Alzheimer’s disease patients—a pilot study
Košiček, M., Kirsch, S., Béné, R., Trkanjec, Z., Titlić, M., Bîndilă, L., Peter‐Katalinić, J., & Hecimovic, S. K. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-4273-8 · Cited by 67
Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A2 in a spatial-specific manner
Palavicini, J. P., Wang, C., Chen, L., HoSang, K. M., Wang, J., Tomiyama, T., Mori, H., & Han, X. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0460-6 · Cited by 62
Self-citation
Abundance of triacylglycerols in ganglia and their depletion in diabetic mice: implications for the role of altered triacylglycerols in diabetic neuropathy
Cheng, H., Guan, S., & Han, X. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03794.x · Cited by 62
Self-citation
Analysis of Serum Metabolic Profile by Ultra-performance Liquid Chromatography-mass Spectrometry for Biomarkers Discovery
Feng, S., Du, Y., Li, Z., Zhang, L., Feng, R.-R., & Liu, S.-Y. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.149188 · Cited by 61
Hydroxylated and non-hydroxylated sulfatide are distinctly distributed in the human cerebral cortex
Yuki, D., Sugiura, Y., Zaima, N., Akatsu, H., Hashizume, Y., Yamamoto, T., Fujiwara, M., Sugiyama, K., & Setou, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.045 · Cited by 61
Lactosylceramide: a lipid second messenger in neuroinflammatory disease
Won, J., Singh, A. K., & Singh, I. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04822.x · Cited by 60
Elevation of the level and activity of acid ceramidase in Alzheimer's disease brain
Huang, Y., Tanimukai, H., Liu, F., Iqbal, K., Grundke, I., & Gong, C. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03852.x · Cited by 60
Anti-apoptotic and anti-oxidative mechanisms of minocycline against sphingomyelinase/ceramide neurotoxicity: implication in Alzheimer's disease and cerebral ischemia
Chen, S., Yin, J., Hwang, C., Tang, C.-M., & Yang, D. (2012) · Free Radical Research · doi:10.3109/10715762.2012.674640 · Cited by 59
Critical Role for Sphingosine Kinase-1 in Regulating Survival of Neuroblastoma Cells Exposed to Amyloid-β Peptide
Gomez‐Brouchet, A., Pchejetski, D., Brizuela, L., Garcia, V., Altié, M.-F., Maddelein, M., Delisle, M., & Cuvillier, O. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033738 · Cited by 60
Neuronal human BACE1 knockin induces systemic diabetes in mice
Plucińska, K., Dekeryte, R., Koss, D., Shearer, K., Mody, N., Whitfield, P. D., Doherty, M. K., Mingarelli, M., Welch, A., Riedel, G., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-3960-1 · Cited by 58
GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology
Michno, W., Wehrli, P. M., Zetterberg, H., Blennow, K., & Hanrieder, J. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.09.010 · Cited by 60
The Full Spectrum of Alzheimer’s Disease Is Rooted in Metabolic Derangements That Drive Type 3 Diabetes
de la Monte, S. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_4 · Cited by 59
Sulfatide with short fatty acid dominates in astrocytes and neurons
Isaac, G., Pernber, Z., Gieselmann, V., Hansson, E. K., Bergquist, J., & Månsson, J. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05195.x · Cited by 58
Metabonomic Profiling of TASTPM Transgenic Alzheimer’s Disease Mouse Model
Hu, Z., Browne, E. R., Liu, T., Angel, T. E., Ho, P. C., & Chan, E. C. Y. (2012) · Journal of Proteome Research · doi:10.1021/pr300666p · Cited by 58
Annotation of the human cerebrospinal fluid lipidome using high resolution mass spectrometry and a dedicated data processing workflow
Seyer, A., Boudah, S., Broudin, S., Junot, C., & Colsch, B. (2016) · Metabolomics · doi:10.1007/s11306-016-1023-8 · Cited by 68
Comprehensive genomic analyses associate UGT8 variants with musical ability in a Mongolian population
Park, H., Lee, S., Kim, H., Ju, Y. S., Shin, J.-Y., Hong, D., von Grotthuss, M., Lee, D.-S., Park, C., Kim, J. H., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101209 · Cited by 60
Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer’s disease?
Mielke, M. M., & Haughey, N. J. (2012) · Clinical Lipidology · doi:10.2217/clp.12.59 · Cited by 56
Layer-specific sulfatide localization in rat hippocampus middle molecular layer is revealed by nanoparticle-assisted laser desorption/ionization imaging mass spectrometry
Ageta, H., Asai, S., Sugiura, Y., Goto‐Inoue, N., Zaima, N., & Setou, M. (2009) · Medical Molecular Morphology · doi:10.1007/s00795-008-0427-6 · Cited by 55
Lipid metabolism in microglia: Emerging mechanisms and therapeutic opportunities for neurodegenerative diseases (Review)
Sun, Y., Wei, K., Liao, X., Wang, J., Gao, L., & Pang, B. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5580 · Cited by 63
Vitamin K Deficiency Induced by Warfarin Is Associated With Cognitive and Behavioral Perturbations, and Alterations in Brain Sphingolipids in Rats
Tamadon‐Nejad, S., Ouliass, B., Rochford, J. M., & Ferland, G. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00213 · Cited by 54
Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson’s disease primate model
Kaya, I., Nilsson, A., Luptáková, D., He, Y., Vallianatou, T., Bjärterot, P., Svenningsson, P., Bézard, E., & Andrén, P. E. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00558-1 · Cited by 57
Impaired memory and olfactory performance in NaSi-1 sulphate transporter deficient mice
Dawson, P. A., Steane, S. E., & Markovich, D. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.09.020 · Cited by 53
Aluminum-Induced Entropy in Biological Systems: Implications for Neurological Disease
Shaw, C. A., Seneff, S., Kette, S. D., Tomljenovic, L., Oller, J. W., & Davidson, R. M. (2014) · Journal of Toxicology · doi:10.1155/2014/491316 · Cited by 59
Metal and complementary molecular bioimaging in Alzheimer's disease
Braidy, N., Poljak, A., Marjo, C. E., Rutlidge, H., Rich, A. M., Jayasena, T., Inestrosa, N. C., & Sachdev, P. S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00138 · Cited by 53
Multimodal Chemical Imaging of Amyloid Plaque Polymorphism Reveals Aβ Aggregation Dependent Anionic Lipid Accumulations and Metabolism
Michno, W., Kaya, I., Nyström, S., Guérard, L., Nilsson, K. P. R., Hammarström, P., Blennow, K., Zetterberg, H., & Hanrieder, J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01361 · Cited by 54
Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine‐1‐phosphate mediated mechanisms
Norman, E. D., Cutler, R. G., Flannery, R. J., Wang, Y., & Mattson, M. P. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06779.x · Cited by 52
Lipidomics of Alzheimer’s Disease
Touboul, D., & Gaudin, M. (2014) · Bioanalysis · doi:10.4155/bio.13.346 · Cited by 52
Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study
Chatterjee, P., Lim, W. L. F., Shui, G., Gupta, V. B., JAMES, I. R., Fagan, A. M., Xiong, C., Sohrabi, H. R., Taddei, K., Brown, B. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150948 · Cited by 49
Self-citation
Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer';s Disease and Mild Cognitive Impairment
González‐Domínguez, R., Rupérez, F. J., García‐Barrera, T., Barbas, C., & Gómez‐Ariza, J. L. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160129095138 · Cited by 55
The use of MALDI‐MSI in the investigation of psychiatric and neurodegenerative disorders: A review
Schubert, K. O., Weiland, F., Baune, B. T., & Hoffmann, P. (2016) · PROTEOMICS · doi:10.1002/pmic.201500460 · Cited by 51
Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix‐assisted laser desorption/ionization‐imaging mass spectrometry
Mendis, L. H. S., Grey, A. C., Faull, R. L. M., & Curtis, M. A. (2016) · Brain and Behavior · doi:10.1002/brb3.517 · Cited by 50
Subventricular zone lipidomic architecture loss in Huntington's disease
Hunter, M., Demarais, N. J., Faull, R. L. M., Grey, A. C., & Curtis, M. A. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14468 · Cited by 52
Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease
Geekiyanage, H., Upadhye, A., & Chan, C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.001 · Cited by 52
Intact lipid imaging of mouse brain samples: MALDI, nanoparticle-laser desorption ionization, and 40 keV argon cluster secondary ion mass spectrometry
Mohammadi, A. S., Phan, N. T. N., Fletcher, J. S., & Ewing, A. G. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9812-5 · Cited by 52
The Roles of Neutral Sphingomyelinases in Neurological Pathologies
Horres, C. R., & Hannun, Y. A. (2012) · Neurochemical Research · doi:10.1007/s11064-011-0692-y · Cited by 50
Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains
Hejazi, L., Wong, J. W. H., Cheng, D., Proschogo, N. W., Ebrahimi, D., Garner, B., & Don, A. S. (2011) · Biochemical Journal · doi:10.1042/bj20110566 · Cited by 49
Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis
Busto, R., Serna, J., Perianes‐Cachero, A., Quintana‐Portillo, R., García‐Seisdedos, D., Canfrán‐Duque, A., Paíno, C. L., Lerma, M., Casado, M. E., Martín‐Hidalgo, A., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.05.009 · Cited by 49
Comprehensive MS/MS profiling by UHPLC-ESI-QTOF-MS/MS using SWATH data-independent acquisition for the study of platelet lipidomes in coronary artery disease
Schlotterbeck, J., Chatterjee, M., Gawaz, M., & Lämmerhofer, M. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.08.060 · Cited by 50
Early disruption of nerve mitochondrial and myelin lipid homeostasis in obesity-induced diabetes
Palavicini, J. P., Chen, J., Wang, C., Wang, J., Qin, C., Baeuerle, E., Wang, X., Woo, J. A., Kang, D. E., Musi, N., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137286 · Cited by 51
Self-citation
Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease
Byeon, S. K., Madugundu, A. K., Jain, A., Bhat, F. A., Jung, J. H., Renuse, S., Darrow, J. A., Bakker, A., Albert, M., Moghekar, A., et al. (2021) · Molecular Omics · doi:10.1039/d0mo00186d · Cited by 50
Potential of metabolomics in preclinical and clinical drug development
Kumar, B., Prakash, A., Ruhela, R. K., & Medhi, B. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.06.010 · Cited by 48
Age-dependent changes in nervonic acid-containing sphingolipids in mouse hippocampus
Vozella, V., Basit, A., Misto, A., & Piomelli, D. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.08.008 · Cited by 50
Lipid Metabolism and Lipidomics Applications in Cancer Research
Pan, M., Qin, C., & Han, X. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6785-2_1 · Cited by 50
Self-citation
Diverse roles of ceramide in the progression and pathogenesis of Alzheimer's disease
Chowdhury, M. R., Jin, H. K., & Bae, J.-S. (2022) · Biomedicines · doi:10.3390/biomedicines10081956 · Cited by 47
Lipidomic Profiles in Diabetes and Dementia
Huynh, K., Martins, R. N., & Meikle, P. J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161215 · Cited by 47
Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer’s disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry
Kim, S. H., Yang, J. S., Lee, J. C., Lee, J.-Y., Lee, J., Kim, E., & Moon, M. H. (2018) · Journal of Chromatography A · doi:10.1016/j.chroma.2018.07.018 · Cited by 47
Sphingolipids in food and their critical roles in human health
Wang, X., Wang, Y., Xu, J., & Xue, C. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1736510 · Cited by 46
Sulfatide in health and disease. The evaluation of sulfatide in cerebrospinal fluid as a possible biomarker for neurodegeneration
Blomqvist, M., Zetterberg, H., Blennow, K., & Månsson, J. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2021.103670 · Cited by 47
The Pathogenic Implication of Abnormal Interaction Between Apolipoprotein E Isoforms, Amyloid-beta Peptides, and Sulfatides in Alzheimer’s Disease
Han, X. (2010) · Molecular Neurobiology · doi:10.1007/s12035-009-8092-x · Cited by 47
Self-citation
Association studies of 23 positional/functional candidate genes on chromosome 10 in late‐onset Alzheimer's disease
Morgan, A. R., Turic, D., Jehu, L., Hamilton, G., Hollingworth, P., Moskvina, V., Jones, L., Lovestone, S., Brayne, C., Rubinsztein, D. C., et al. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30509 · Cited by 42
Rapid demonstration of diversity of sulfatide molecular species from biological materials by MALDI-TOF MS
Kyogashima, M., Tamiya‐Koizumi, K., Ehara, T., Li, G., Hu, R., Hara, A., Aoyama, T., & Kannagi, R. (2006) · Glycobiology · doi:10.1093/glycob/cwj122 · Cited by 46
Multiple Precursor Ion Scanning of Gangliosides and Sulfatides with a Reversed-Phase Microfluidic Chip and Quadrupole Time-of-Flight Mass Spectrometry
Lee, H., Lerno, L., Choe, Y., Chu, C. S., Gillies, L. A., Grimm, R., Lebrilla, C. B., & German, J. B. (2012) · Analytical Chemistry · doi:10.1021/ac300254d · Cited by 46
Prospective associations of plasma phospholipids and mild cognitive impairment/dementia among African Americans in the ARIC Neurocognitive Study
Li, D., Misialek, J. R., Boerwinkle, E., Gottesman, R. F., Sharrett, A. R., Mosley, T. H., Coresh, J., Wruck, L. M., Knopman, D. S., & Alonso, Á. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.09.003 · Cited by 43
Lipid mapping of the rat brain for models of disease
Martínez‐Gardeazabal, J., Román, E. G. D. S., Moreno‐Rodríguez, M., Llorente‐Ovejero, A., Manuel, I., & Rodríguez‐Puertas, R. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.02.011 · Cited by 45
Androgens, ApoE, and Alzheimer's Disease
Raber, J. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.11.re2 · Cited by 48
A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer’s disease, and their co-morbidities
Pan, Y., Li, J., Lin, P., Wan, L., Qu, Y., Cao, L., & Wang, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1348410 · Cited by 49
New insights into cardiovascular and lipid metabolomics
Giovane, A., Antonio, B., & Claudio Napoli, A. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21875 · Cited by 44
MALDI Orbitrap Mass Spectrometry Profiling of Dysregulated Sulfoglycosphingolipids in Renal Cell Carcinoma Tissues
Jirásko, R., Holčapek, M., Khalikova, M. A., Vrána, D., Študent, V., Prouzová, Z., & Melichar, B. (2017) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-017-1644-9 · Cited by 44
Systems healthcare: a holistic paradigm for tomorrow
Fiandaca, M. S., Mapstone, M. E., Connors, E. E., Jacobson, M., Monuki, E. S., Malik, S., Macciardi, F. M., & Federoff, H. J. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0521-2 · Cited by 49
Activation of Mitochondrial Unfolded Protein Response in SHSY5Y Expressing APP Cells and APP/PS1 Mice
Shen, Y., Ding, M., Xie, Z., Liu, X., Yang, H., Jin, S., Xu, S., Zhu, Z., Wang, Y., Wang, D., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00568 · Cited by 45
CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer’s disease
Crivelli, S. M., Luo, Q., Stevens, J., Giovagnoni, C., van Kruining, D., Bode, G. H., den Hoedt, S., Hobo, B., Scheithauer, A.-L., Walter, J., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00780-0 · Cited by 41
Biomarkers for Psychiatric Disorders
Turck, C. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-79251-4 · Cited by 42
High-fat diet-induced lipidome perturbations in the cortex, hippocampus, hypothalamus, and olfactory bulb of mice
Lee, J. C., Park, S. M., Kim, I. Y., Sung, H., Seong, J. K., & Moon, M. H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.05.007 · Cited by 43
Recent advances in the mass spectrometric analysis of glycosphingolipidome – A review
Barrientos, R. C., & Zhang, Q. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.05.051 · Cited by 43
Biological Markers in Alzheimer's Disease
Bailey, P. (2007) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100005618 · Cited by 43
HFE gene variants, iron, and lipids: a novel connection in Alzheimer’s disease
Ali-Rahmani, F. G., Schengrund, C., & Connor, J. R. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00165 · Cited by 43
Functional Inhibitors of Acid Sphingomyelinase (FIASMAs)
Kornhuber, J., Tripal, P., Gulbins, E., & Muehlbacher, M. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-7091-1368-4_9 · Cited by 42
Inhibitory effect of sesaminol glucosides on lipopolysaccharide-induced NF-κB activation and target gene expression in cultured rat astrocytes
Lee, S. Y., Son, D. J., Lee, Y. K., Lee, J. W., Lee, H. J., Yun, Y. W., Ha, T. Y., & Hong, J. T. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.06.005 · Cited by 42
Acetylcholinesterase inhibitors may improve myelin integrity
Bartzokis, G. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.020 · Cited by 41
Mammalian protein glycosylation – structure versus function
Defaus, S., Gupta, P., Andreu, D., & Gallego, R. G. (2014) · The Analyst · doi:10.1039/c3an02245e · Cited by 44
Glucosylceramide synthase decrease in frontal cortex of Alzheimer brain correlates with abnormal increase in endogenous ceramides: Consequences to morphology and viability on enzyme suppression in cultured primary neurons
Marks, N., Berg, M. J., Saito, M., & Saito, M. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.066 · Cited by 41
Aluminum and Glyphosate Can Synergistically Induce Pineal Gland Pathology: Connection to Gut Dysbiosis and Neurological Disease
Seneff, S., Swanson, N., & Li, C. (2015) · Agricultural Sciences · doi:10.4236/as.2015.61005 · Cited by 43
The Molecular Mechanism of Amyloid β42 Peptide Toxicity: The Role of Sphingosine Kinase-1 and Mitochondrial Sirtuins
Cieślik, M., Czapski, G. A., & Strosznajder, J. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137193 · Cited by 43
The silence of the fats: A MAM’s story about Alzheimer
Agrawal, R. R., Montesinos, J., Larrea, D., Área-Gómez, E., & Pera, M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105062 · Cited by 42
Late endocytic dysfunction as a putative cause of amyloid fibril formation in Alzheimer’s disease
Yuyama, K., & Yanagisawa, K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06046.x · Cited by 40
Instability of the cellular lipidome with age
Hughes, J. R., Deeley, J. M., Blanksby, S. J., Leisch, F., Ellis, S. R., Truscott, R. J. W., & Mitchell, T. W. (2011) · AGE · doi:10.1007/s11357-011-9293-6 · Cited by 42
Abnormal Sphingolipid World in Inflammation Specific for Lysosomal Storage Diseases and Skin Disorders
Moskot, M., Bocheńska, K., Jakóbkiewicz‐Banecka, J., Banecki, B., & Gabig‐Cimińska, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010247 · Cited by 42
Neuro-nutrients as anti-alzheimer's disease agents: A critical review
Ravi, S. K., Narasingappa, R. B., & Vincent, B. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1481012 · Cited by 41
White matter alterations in Alzheimer’s disease without concomitant pathologies
Ferrer, I., & Andrés‐Benito, P. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12618 · Cited by 38
Metabolomics in degenerative brain diseases
Escobar, M. Q., Pontes, J. G. D. M., & Tasić, L. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147704 · Cited by 41
The role of lipids in autophagy and its implication in neurodegeneration
Hernández-Díaz, S., & Soukup, S. (2020) · Cell Stress · doi:10.15698/cst2020.07.225 · Cited by 39
Behavioural abnormalities of the hyposulphataemic Nas1 knock-out mouse
Dawson, P. A., Steane, S. E., & Markovich, D. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.03.013 · Cited by 39
Correction: Biomarkers of Inflammation, Immunosuppression and Stress with Active Disease Are Revealed by Metabolomic Profiling of Tuberculosis Patients
Weiner, J., Parida, S. K., Maertzdorf, J., Black, G. F., Repsilber, D., Telaar, A., Mohney, R. P., Arndt-Sullivan, C., Ganoza, C. A., FaÃ©, K. C., et al. (2012) · PLoS ONE · doi:10.1371/annotation/b7f554bc-ad78-4745-9cd6-e14954d6a01d · Cited by 38
Analytical approaches to the diagnosis and treatment of aging and aging-related disease: redox status and proteomics
Calabrese, V., Dattilo, S., Petralia, A., Parenti, R., Pennisi, M., Koverech, G., Calabrese, V., Graziano, A., Monte, I. P., Maiolino, L., et al. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1020799 · Cited by 39
Computational Methods for the Discovery of Metabolic Markers of Complex Traits
Lee, M. Y., & Hu, T. (2019) · Metabolites · doi:10.3390/metabo9040066 · Cited by 39
Endosomes and lysosomes play distinct roles in sulfatide-induced neuroblastoma apoptosis: potential mechanisms contributing to abnormal sulfatide metabolism in related neuronal diseases
Zeng, Y., Cheng, H., Jiang, X., & Han, X. (2008) · Biochemical Journal · doi:10.1042/bj20070976 · Cited by 38
Self-citation
Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer’s Disease
Lista, S., Khachaturian, Z. S., Rujescu, D., Garaci, F., Dubois, B., & Hampel, H. J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_2 · Cited by 39
Neuronal Cholesterol Accumulation Induced by Cyp46a1 Down-Regulation in Mouse Hippocampus Disrupts Brain Lipid Homeostasis
Ayciriex, S., Djelti, F., Alves, S., Regazzetti, A., Gaudin, M., Varin, J., Langui, D., Bièche, I., Hudry, E., Dargère, D., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00211 · Cited by 40
Particular CSF sphingolipid patterns identify iNPH and AD patients
Torretta, E., Arosio, B., Barbacini, P., Casati, M., Capitanio, D., Mancuso, R., Mari, D., Cesari, M., Clerici, M., & Gelfi, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-31756-0 · Cited by 38
Gender-dependent accumulation of ceramides in the cerebral cortex of the APPSL/PS1Ki mouse model of Alzheimer’s disease
Barrier, L., Ingrand, S. S., Fauconneau, B., & Page, G. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.10.011 · Cited by 36
Neural Metabolic Networks: Key Elements of Healthy Brain Function
Madrer, N., Perera, N. D., Uccelli, N. A., Abbondanza, A., Andersen, J. V., Carsana, E. V., Demmings, M. D., Fernandez, R. F., de Fragas, M. G., Gbadamosi, I., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70084 · Cited by 37
Differential Sphingolipid and Phospholipid Profiles in Alcohol and Nicotine‐Derived Nitrosamine Ketone‐Associated White Matter Degeneration
Yalcin, E. B., Nuñez, K. M., Tong, M., & de la Monte, S. M. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12909 · Cited by 35
Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice
Shang, Y., Mishra, A., Wang, T., Wang, Y., Desai, M. K., Chen, S., Mao, Z., Do, L., Bernstein, A. S., Trouard, T. P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0225392 · Cited by 36
The possible role of myelin destruction as a precipitating event in Alzheimer’s disease
Noble, M. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.07.001 · Cited by 35

Authors: Han, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C.
Affiliations: Washington University in St. Louis (US)
Corresponding author: Han, Xianlin
ORCID: Han, Xianlin
Morris, John C.
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 2002-08
Volume: 82
Issue: 4
Pages: 809-818
ISSN: 0022-3042 (ISSN-L)
1471-4159
DOI: 10.1046/j.1471-4159.2002.00997.x
OpenAlex: W1594975246
Cited by: 626
References: 56
Citations by year: 2026: 24 · 2025: 26 · 2024: 29 · 2023: 32 · 2022: 32 · 2021: 29 · 2020: 32 · 2019: 22 · 2018: 29 · 2017: 33 · 2016: 34 · 2015: 24 · 2014: 33 · 2013: 33 · 2012: 36
FWCI: 7.61
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 6 d)
Locations: Journal of Neurochemistry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p41rr000954-34)
National Institute on Aging (P 50 AG05681, P50AG005681, P01 AG0 3991, P01AG003991)
National Center for Research Resources (P41RR00954-240043)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, sulfatide, ceramide, white matter, gray matter, brain lipid composition, pathogenesis
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Brain, Brain Chemistry, Ceramides, Dementia, Galactosylceramides, Humans, Neuropsychological Tests, Severity of Illness Index, Sphingomyelins, Sulfoglycosphingolipids, Sulfotransferases, Disease Progression, Spectrometry, Mass, Electrospray Ionization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks